Nurix Therapeutics Stock Analysis

Nurix Stock Analysis Notes

About 98.0% of the company shares are owned by institutional investors. The book value of Nurix Therapeutics was now reported as 5.62. The company recorded a loss per share of 2.9. Nurix Therapeutics had not issued any dividends in recent years. Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company was incorporated in 2009 and is headquartered in San Francisco, California. Nurix Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 242 people. To find out more about Nurix Therapeutics contact the company at 415 660 5320 or learn more at https://www.nurixtx.com.

Nurix Therapeutics Investment Alerts

Nurix Therapeutics Upcoming and Recent Events

Nurix Largest EPS Surprises

View All Earnings Estimates

Nurix Therapeutics Environmental, Social, and Governance (ESG) Scores

Nurix Stock Institutional Investors

Note, although Nurix Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Nurix Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.5 B.

Nurix Profitablity

Management Efficiency

Nurix Therapeutics has return on total asset (ROA) of (0.2946) % which means that it has lost $0.2946 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5796) %, meaning that it created substantial loss on money invested by shareholders. Nurix Therapeutics' management efficiency ratios could be used to measure how well Nurix Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.49 in 2024. Return On Capital Employed is likely to drop to -0.55 in 2024. At this time, Nurix Therapeutics' Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to rise to about 5.7 M in 2024, whereas Total Assets are likely to drop slightly above 318.1 M in 2024.

Technical Drivers

As of the 28th of November, Nurix Therapeutics secures the Risk Adjusted Performance of (0.03), mean deviation of 2.39, and Standard Deviation of 3.38. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nurix Therapeutics, as well as the relationship between them.

Nurix Therapeutics Price Movement Analysis

Nurix Therapeutics Insider Trading Activities

Nurix Therapeutics Outstanding Bonds

Nurix Therapeutics Predictive Daily Indicators

Nurix Therapeutics Corporate Filings

Nurix Therapeutics Forecast Models

Nurix Therapeutics' time-series forecasting models are one of many Nurix Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Nurix Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Nurix Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Nurix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Nurix Therapeutics. By using and applying Nurix Stock analysis, traders can create a robust methodology for identifying Nurix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Nurix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Nurix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Nurix Therapeutics stock analysis indicators help investors evaluate how Nurix Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Nurix Therapeutics shares will generate the highest return on investment. By understating and applying Nurix Therapeutics stock analysis, traders can identify Nurix Therapeutics position entry and exit signals to maximize returns.

When running Nurix Therapeutics' price analysis, check to measure Nurix Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix Therapeutics is operating at the current time. Most of Nurix Therapeutics' value examination focuses on studying past and present price action to predict the probability of Nurix Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix Therapeutics' price. Additionally, you may evaluate how the addition of Nurix Therapeutics to your portfolios can decrease your overall portfolio volatility.